BACKGROUND Preoperative evaluation of ovarian tumors is challenging. This study was undertaken to evaluate the performance of conventional two-dimensional (2D) ultrasound and CA125 in predicting malignant or benign nature of pelvic masses, and to investigate if three-dimensional power Doppler (3DPD) ultrasound provides any added value. Ninety-six postmenopausal and four perimenopausal women wit...

Cancer antigen 125 (CA 125) is a useful tumor marker with a threshold value of 35 U mL(-1) expressed by more than 80% of patients with non-mucinous epithelial ovarian cancer. In this work, a novel strategy for the analysis of CA 125 using the plasmon resonance scattering (PRS) properties of gold nanorods was proposed. The gold nanorod (GNR)-anti-CA 125 conjugates were prepared first. The immuno...

background: ca-125 is a glycoprotein and its origin is uncertain during pregnancy. it arises during the first trimester and return to a non-pregnancy range in late pregnancy. objective: the aim of this study was to compare ca-125 level in threatened abortion and normal pregnancy less than 20 weeks of pregnancy. materials and methods: this was a prospective case study carried out on 50 healthy p...

CA 125 Adenomyosis Immunohistochemistry Abstract To investigate the histogenic and cytogenic localization of CA 125 in patients with adenomyosis, sections from 8 adenomyosis cases were expressed with monoclonal anti-CA 125 antibodies. Consequently, CA 125 proved to be present on the glandular epithelium localized in muscle layers of adenomyosis. S. Kijima, Department of Obstetrics and Gynecolog...